CRLS - Chrysalis : Any followers ? Any comments ? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CRLS - Chrysalis : Any followers ? Any comments ?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Charlotte Hall who wrote (10)	3/9/1997 10:26:00 PM
From: Craig Kaltner	of 51

Here's the article.. I'm also planning to buy on Monday. I think with this and the clone news the stock should get some upward momentum. [ Business - Company - Industry - Finance - PR News - Business Wire Sunday March 9 4:53 PM EST Barron's columnist Abelson touts Chrysalis( Chrysalis International Corp ) NEW YORK, March 9 (Reuter) - In his March 10 "Up & Down Wall Street" column, Barron's Alan Abelson plugged Chrysalis International Corp, a small biotech firm that last week warned of a loss for the fourth quarter 1996, before one-time charges. Abelson said Chrysalis acts as an outsourcer of research for drug houses and, to a lesser extent, other biotechs. The column said outsourcing is a strong trend in the drug business. Abelson cites "a savvy investor who owns the stock" and sees Chrysalis growing 20 percent to 25 percent a year "for quite a spell." The column said a merger recently completed by Chrysalis "took a bit more doing than anticipated, which explains the disappointing fourth quarter." Abelson said Chrysalis has an exclusive license to a patent covering a DNA microinjection process, widely used to transfer genes in the development of transgenic animals. So, the column said, "just about anyone doing work in the microinjection area has to pony up a royalty to Chrysalis." ------------------------------------------------------------------------ Help ------------------------------------------------------------------------ Back to U.S. Stock News and Report news page ------------------------------------------------------------------------ Copyright c 1997 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon Questions or Comments?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next